CN108753855A - The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins - Google Patents
The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins Download PDFInfo
- Publication number
- CN108753855A CN108753855A CN201810524408.7A CN201810524408A CN108753855A CN 108753855 A CN108753855 A CN 108753855A CN 201810524408 A CN201810524408 A CN 201810524408A CN 108753855 A CN108753855 A CN 108753855A
- Authority
- CN
- China
- Prior art keywords
- fermentation
- metabolites
- intracellular
- lactic acid
- wgcna
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000855 fermentation Methods 0.000 title claims abstract description 84
- 230000004151 fermentation Effects 0.000 title claims abstract description 79
- 238000000034 method Methods 0.000 title claims abstract description 41
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 title claims abstract description 36
- 239000002207 metabolite Substances 0.000 claims abstract description 57
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims abstract description 40
- 230000003834 intracellular effect Effects 0.000 claims abstract description 27
- 229910052757 nitrogen Inorganic materials 0.000 claims abstract description 19
- 238000001514 detection method Methods 0.000 claims abstract description 15
- 238000005457 optimization Methods 0.000 claims abstract description 14
- 241000186673 Lactobacillus delbrueckii Species 0.000 claims abstract description 13
- 238000011160 research Methods 0.000 claims abstract description 8
- 230000004060 metabolic process Effects 0.000 claims abstract description 5
- 238000013178 mathematical model Methods 0.000 claims abstract description 4
- 238000004458 analytical method Methods 0.000 claims description 16
- 238000002290 gas chromatography-mass spectrometry Methods 0.000 claims description 14
- 238000005516 engineering process Methods 0.000 claims description 13
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 12
- 238000001294 liquid chromatography-tandem mass spectrometry Methods 0.000 claims description 11
- 239000000284 extract Substances 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 7
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims description 6
- 239000001888 Peptone Substances 0.000 claims description 6
- 108010080698 Peptones Proteins 0.000 claims description 6
- 235000019319 peptone Nutrition 0.000 claims description 6
- 239000000843 powder Substances 0.000 claims description 6
- 230000008859 change Effects 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 4
- 235000015278 beef Nutrition 0.000 claims description 4
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 claims description 4
- 239000000920 calcium hydroxide Substances 0.000 claims description 4
- 229910001861 calcium hydroxide Inorganic materials 0.000 claims description 4
- 230000008569 process Effects 0.000 claims description 4
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 3
- 229910000019 calcium carbonate Inorganic materials 0.000 claims description 3
- 239000001301 oxygen Substances 0.000 claims description 3
- 229910052760 oxygen Inorganic materials 0.000 claims description 3
- 230000033228 biological regulation Effects 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims 2
- 238000012512 characterization method Methods 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- 239000012530 fluid Substances 0.000 claims 1
- 238000000491 multivariate analysis Methods 0.000 claims 1
- 238000005070 sampling Methods 0.000 claims 1
- 229930182843 D-Lactic acid Natural products 0.000 abstract description 29
- 229940022769 d- lactic acid Drugs 0.000 abstract description 29
- 230000002503 metabolic effect Effects 0.000 abstract description 20
- 230000002596 correlated effect Effects 0.000 abstract description 6
- 229910001873 dinitrogen Inorganic materials 0.000 abstract description 2
- 230000001105 regulatory effect Effects 0.000 abstract 1
- 238000002705 metabolomic analysis Methods 0.000 description 19
- 230000001431 metabolomic effect Effects 0.000 description 19
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 12
- 239000006228 supernatant Substances 0.000 description 11
- 210000004027 cell Anatomy 0.000 description 9
- 238000003012 network analysis Methods 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 230000015556 catabolic process Effects 0.000 description 8
- 238000006731 degradation reaction Methods 0.000 description 8
- 239000000090 biomarker Substances 0.000 description 7
- 150000002500 ions Chemical class 0.000 description 7
- 230000007246 mechanism Effects 0.000 description 7
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 6
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 6
- 244000005700 microbiome Species 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 238000007405 data analysis Methods 0.000 description 5
- 239000000417 fungicide Substances 0.000 description 5
- 238000007619 statistical method Methods 0.000 description 5
- 241000316848 Rhodococcus <scale insect> Species 0.000 description 4
- 238000004128 high performance liquid chromatography Methods 0.000 description 4
- 238000002347 injection Methods 0.000 description 4
- 239000007924 injection Substances 0.000 description 4
- 238000004949 mass spectrometry Methods 0.000 description 4
- 239000007921 spray Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000001212 derivatisation Methods 0.000 description 3
- 230000006872 improvement Effects 0.000 description 3
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 3
- 230000010534 mechanism of action Effects 0.000 description 3
- 239000012528 membrane Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 125000005575 polycyclic aromatic hydrocarbon group Chemical group 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 230000009897 systematic effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- NGHMDNPXVRFFGS-IUYQGCFVSA-N D-erythrose 4-phosphate Chemical compound O=C[C@H](O)[C@H](O)COP(O)(O)=O NGHMDNPXVRFFGS-IUYQGCFVSA-N 0.000 description 2
- FNZLKVNUWIIPSJ-RFZPGFLSSA-N D-xylulose 5-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-RFZPGFLSSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 2
- PPQRONHOSHZGFQ-LMVFSUKVSA-N aldehydo-D-ribose 5-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@@H](O)[C@@H](O)C=O PPQRONHOSHZGFQ-LMVFSUKVSA-N 0.000 description 2
- 229940040526 anhydrous sodium acetate Drugs 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- KLOIYEQEVSIOOO-UHFFFAOYSA-N carbocromen Chemical compound CC1=C(CCN(CC)CC)C(=O)OC2=CC(OCC(=O)OCC)=CC=C21 KLOIYEQEVSIOOO-UHFFFAOYSA-N 0.000 description 2
- 230000000875 corresponding effect Effects 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000000855 fungicidal effect Effects 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 239000011159 matrix material Substances 0.000 description 2
- 230000004066 metabolic change Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000037361 pathway Effects 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 239000004033 plastic Substances 0.000 description 2
- 229920003023 plastic Polymers 0.000 description 2
- 239000004626 polylactic acid Substances 0.000 description 2
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 2
- 229920000053 polysorbate 80 Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000000513 principal component analysis Methods 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- JDTUMPKOJBQPKX-GBNDHIKLSA-N sedoheptulose 7-phosphate Chemical compound OCC(=O)[C@@H](O)[C@H](O)[C@H](O)[C@H](O)COP(O)(O)=O JDTUMPKOJBQPKX-GBNDHIKLSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 238000000825 ultraviolet detection Methods 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- FBPFZTCFMRRESA-GVZKVBLJSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol Chemical compound O[13CH2][13C@H](O)[13C@@H](O)[13C@H](O)[13C@H](O)[13CH2]O FBPFZTCFMRRESA-GVZKVBLJSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-L (R)-2-Hydroxy-3-(phosphonooxy)-propanal Natural products O=C[C@H](O)COP([O-])([O-])=O LXJXRIRHZLFYRP-VKHMYHEASA-L 0.000 description 1
- YFMLAZBUXVEFHJ-UHFFFAOYSA-N 2,2,2-trifluoro-N-silylacetamide Chemical compound FC(F)(F)C(=O)N[SiH3] YFMLAZBUXVEFHJ-UHFFFAOYSA-N 0.000 description 1
- CWVUGRRNPKOWFB-UHFFFAOYSA-N 2-chloro-3-(4-chlorophenyl)quinoline Chemical compound C1=CC(Cl)=CC=C1C1=CC2=CC=CC=C2N=C1Cl CWVUGRRNPKOWFB-UHFFFAOYSA-N 0.000 description 1
- LXJXRIRHZLFYRP-VKHMYHEASA-N D-glyceraldehyde 3-phosphate Chemical compound O=C[C@H](O)COP(O)(O)=O LXJXRIRHZLFYRP-VKHMYHEASA-N 0.000 description 1
- FNZLKVNUWIIPSJ-UHNVWZDZSA-N D-ribulose 5-phosphate Chemical compound OCC(=O)[C@H](O)[C@H](O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHNVWZDZSA-N 0.000 description 1
- 229940124186 Dehydrogenase inhibitor Drugs 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000186660 Lactobacillus Species 0.000 description 1
- 101000707232 Mus musculus SH2 domain-containing protein 2A Proteins 0.000 description 1
- FNZLKVNUWIIPSJ-UHFFFAOYSA-N Rbl5P Natural products OCC(=O)C(O)C(O)COP(O)(O)=O FNZLKVNUWIIPSJ-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 102000019259 Succinate Dehydrogenase Human genes 0.000 description 1
- 108010012901 Succinate Dehydrogenase Proteins 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- VFRROHXSMXFLSN-KCDKBNATSA-N aldehydo-D-galactose 6-phosphate Chemical compound OP(=O)(O)OC[C@@H](O)[C@H](O)[C@H](O)[C@@H](O)C=O VFRROHXSMXFLSN-KCDKBNATSA-N 0.000 description 1
- RNBGYGVWRKECFJ-ZXXMMSQZSA-N alpha-D-fructofuranose 1,6-bisphosphate Chemical compound O[C@H]1[C@H](O)[C@](O)(COP(O)(O)=O)O[C@@H]1COP(O)(O)=O RNBGYGVWRKECFJ-ZXXMMSQZSA-N 0.000 description 1
- 230000003698 anagen phase Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical group O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000007621 cluster analysis Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 229940025237 fructose 1,6-diphosphate Drugs 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 239000001307 helium Substances 0.000 description 1
- 229910052734 helium Inorganic materials 0.000 description 1
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 230000010354 integration Effects 0.000 description 1
- 230000008463 key metabolic pathway Effects 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940039696 lactobacillus Drugs 0.000 description 1
- 238000004895 liquid chromatography mass spectrometry Methods 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000012533 medium component Substances 0.000 description 1
- 230000037353 metabolic pathway Effects 0.000 description 1
- 238000006241 metabolic reaction Methods 0.000 description 1
- GBMDVOWEEQVZKZ-UHFFFAOYSA-N methanol;hydrate Chemical compound O.OC GBMDVOWEEQVZKZ-UHFFFAOYSA-N 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- AFTLVCKDKPSOGG-UHFFFAOYSA-N o-methylhydroxylamine;pyridine;hydrochloride Chemical compound Cl.CON.C1=CC=NC=C1 AFTLVCKDKPSOGG-UHFFFAOYSA-N 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000004108 pentose phosphate pathway Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DTBNBXWJWCWCIK-UHFFFAOYSA-K phosphonatoenolpyruvate Chemical compound [O-]C(=O)C(=C)OP([O-])([O-])=O DTBNBXWJWCWCIK-UHFFFAOYSA-K 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229920000747 poly(lactic acid) Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000009722 regulation of fermentation Effects 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 238000011218 seed culture Methods 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 238000013517 stratification Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000004885 tandem mass spectrometry Methods 0.000 description 1
- 238000010257 thawing Methods 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/40—Preparation of oxygen-containing organic compounds containing a carboxyl group including Peroxycarboxylic acids
- C12P7/56—Lactic acid
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明涉及一种WGCNA识别D‑乳酸发酵过程显著模块和Hubs代谢物的方法;进行D‑乳酸发酵工艺优化研究,包括通氮气维持厌氧发酵环境、调控发酵pH值、更换中和剂、替换廉价氮源,并将上述发酵条件进行组合优化,得到D‑乳酸最优发酵工艺路线;对各种发酵工艺条件下的胞内代谢物进行动态检测,获得D‑乳酸发酵菌株胞内代谢动态变化特征曲线;采用WGCNA的数学模型对步骤2)中测定的胞内代谢物特征进行统计学解析,获得与各个发酵条件高度相关的显著代谢模块和Hubs代谢物。本发明通过系统生物学手段,首次揭示德氏乳杆菌在不同发酵条件下,发酵D‑乳酸的胞内显著差异代谢模块和核心代谢物,指导后续菌种提升和发酵优化。
The invention relates to a method for WGCNA to identify significant modules and Hubs metabolites in the D-lactic acid fermentation process; to conduct optimization research on the D-lactic acid fermentation process, including maintaining the anaerobic fermentation environment with nitrogen gas, regulating the fermentation pH value, replacing neutralizers, replacing Inexpensive nitrogen source, combined optimization of the above fermentation conditions, to obtain the optimal fermentation process route of D-lactic acid; dynamic detection of intracellular metabolites under various fermentation process conditions, to obtain dynamic changes in intracellular metabolism of D-lactic acid fermentation strains Characteristic curve: The mathematical model of WGCNA is used to statistically analyze the characteristics of intracellular metabolites determined in step 2), and obtain significant metabolic modules and Hubs metabolites highly correlated with each fermentation condition. The present invention reveals for the first time the intracellular metabolic modules and core metabolites of significant differences in the fermentation of D-lactic acid by Lactobacillus delbrueckii under different fermentation conditions by means of systems biology, and guides subsequent strain promotion and fermentation optimization.
Description
技术领域technical field
本发明属乳杆菌系统生物学领域,涉及一种德氏乳杆菌(Lactobacillusdelbrueckii,实验室保藏,购买于中国普通微生物菌种保藏管理中心,菌种编号CGMCC1.2624)在多种发酵工艺条件下,采用加权关联网络分析(Weighted correlationnetwork analysis,简称为WGCNA)进行代谢组学数据解析,从而识别显著差异代谢模块和核心(Hubs)代谢物的方法。The invention belongs to the field of lactobacillus systems biology, and relates to a kind of Lactobacillus delbrueckii (Lactobacillus delbrueckii, preserved in the laboratory, purchased from China General Microorganism Culture Collection Management Center, strain number CGMCC1.2624) under various fermentation process conditions, Using weighted correlation network analysis (WGCNA for short) to analyze metabolomics data, so as to identify significantly different metabolic modules and core (Hubs) metabolites.
背景技术Background technique
D-乳酸分子式CH3CHOHCOOH,相对分子量为90.08,CAS号:10326-41-7,是一种最为常见的代谢产物,在食品、化工、农业和医药等行业中的应用非常广泛,是三大传统有机酸之一。D-乳酸作为一个手性中心,是多种手性物质的前体,广泛应用于制药、高效低毒农药及除草剂、化妆品等领域的手性合成。D-乳酸的另一个更为重要的用途是作为合成聚乳酸(PLA)材料的原料单体。聚乳酸近年来受到广泛关注的一种可再生、可回收的新兴塑料,是石油基塑料的潜在替代品。D-lactic acid has a molecular formula of CH 3 CHOHCOOH, a relative molecular weight of 90.08, and a CAS number of 10326-41-7. It is the most common metabolite and is widely used in food, chemical, agricultural and pharmaceutical industries. It is one of the three major One of the traditional organic acids. As a chiral center, D-lactic acid is the precursor of various chiral substances, and is widely used in the chiral synthesis of pharmaceuticals, high-efficiency and low-toxicity pesticides and herbicides, cosmetics and other fields. Another more important use of D-lactic acid is as a raw material monomer for the synthesis of polylactic acid (PLA) materials. Polylactic acid, a renewable and recyclable emerging plastic that has received widespread attention in recent years, is a potential substitute for petroleum-based plastics.
目前,生产D-乳酸的主要方法为微生物发酵法。由于生物发酵法生产D-乳酸兴起的时间不长,目前对国内外对D-乳酸发酵的研究大多停留在胞外研究阶段,如菌种进化、培养基改良和发酵操作条件优化等,对D-乳酸发酵过程的胞内代谢机制的系统研究还未见报道。At present, the main method of producing D-lactic acid is microbial fermentation. Since the production of D-lactic acid by biological fermentation has not been around for a long time, most of the research on D-lactic acid fermentation at home and abroad is still in the extracellular research stage, such as the evolution of strains, the improvement of medium and the optimization of fermentation operating conditions. - A systematic study of the intracellular metabolic mechanism of lactic acid fermentation has not been reported.
作为系统生物学的重要组成部分,代谢组学是继基因组学和蛋白质组学后的又一门新兴学科。对于工业微生物来说,在菌种改造和发酵行为调控的过程中,细胞的多个代谢功能区或代谢途径会同时发生变化,对任何单一点的单独分析都具有局限性,无法全面理解菌体的生理代谢变化机制。只有从系统的角度分析,才能更清晰地了解微生物的代谢行为特征,阐明其代谢作用机制。因此,通过代谢组学分析可以确定与目标产物合成具有高度关联性的关键代谢物或关键代谢途径,从而为菌种改造、工艺优化及过程调控提供确实可行的理论指导。代谢组学技术在农业、环境科学、人类健康等方面应用越来越广泛,相关的发明专利也越来越多。例如,中国农业大学的刘鹏飞等人发明了一种采用代谢组学揭示杀菌剂作用机制的方法(一种基于代谢组学的杀菌剂作用机制研究方法。公开号:CN107796884A),基于GC-MS技术对含杀菌剂和无药对照培养基上培养的病原菌菌丝进行代谢组检测,通过比较代谢组学研究法寻找差异代谢物,排除不同作用机制共有的代谢物,获得目标杀菌剂作用机制的特异性生物标志物,利用生物标志物含量的变化来实现对杀菌剂作用机制的识别及高通量分析。该发明还公开了琥珀酸脱氢酶抑制剂的生物标志物为琥珀酸,利用该发明提供的筛选杀菌剂作用机制生物标志物方法快速、可靠,获得的生物标志物特异性强。利用生物标志物特异性变化可以实现对活性物质作用机制的快速识别及高通量分析。天津大学的贾晓强等人发明了一种利用代谢组学方法提高红球菌降解环芳烃芘能力的方法(基于代谢组学改进红球菌降解条件以提高多环芳烃芘降解率的方法。公开号:CN107796906A),利用代谢组学手段并结合差异显著性分析揭示红球菌降解多环芳烃芘的代谢物差异,进一步阐释与多环芳烃芘降解相关的代谢变化机制。通过对红球菌在不同生长环境下的降解芘能力和代谢水平进行分析,找到与降解芘相关的代谢物,从而优化其降解条件,为多环芳烃芘降解率的提高提供方向,该方法也可为其它降解多环芳烃微生物降解条件的优化研究提供新的思路和方法。美国保洁公司的Honkonen等人发明了一种采用代谢组学方法分析人类皮肤健康状况的方法(Metabonomic methods to assess health ofskin.Patent No.7,761,242),使用代谢组学手段,在治疗过程中从不同皮肤部位或不同时间采集的样本用于诊断皮肤状况或评价各种皮肤治疗效果,识别了与皮肤健康高度关联的生物标志物。目前关于代谢组学在D-乳酸生产过程中的应用方面,还未见有发明专利。As an important part of systems biology, metabolomics is another emerging discipline after genomics and proteomics. For industrial microorganisms, in the process of strain transformation and regulation of fermentation behavior, multiple metabolic functional areas or metabolic pathways of cells will change simultaneously, and the single analysis of any single point has limitations, and it is impossible to fully understand the bacteria mechanism of physiological metabolic changes. Only by analyzing from a systematic point of view can we have a clearer understanding of the metabolic behavior characteristics of microorganisms and clarify their metabolic mechanisms. Therefore, through metabolomics analysis, key metabolites or key metabolic pathways that are highly correlated with the synthesis of target products can be determined, thereby providing practical theoretical guidance for strain transformation, process optimization, and process regulation. Metabolomics technology is more and more widely used in agriculture, environmental science, human health, etc., and there are more and more related invention patents. For example, Liu Pengfei from China Agricultural University and others invented a method using metabolomics to reveal the mechanism of action of fungicides (a method for the study of fungicide action mechanisms based on metabolomics. Publication number: CN107796884A), based on GC-MS technology Metabolome detection was carried out on the mycelium of pathogenic bacteria cultured on the medium containing fungicides and no drug control medium, and the differential metabolites were found by comparative metabolomics research method, and the metabolites shared by different mechanisms of action were excluded, so as to obtain the specificity of the action mechanism of the target fungicide. Biomarkers, using changes in the content of biomarkers to realize the identification and high-throughput analysis of the mechanism of action of fungicides. The invention also discloses that the biomarker of the succinate dehydrogenase inhibitor is succinic acid, and the biomarker screening method provided by the invention is fast and reliable, and the obtained biomarker has strong specificity. Rapid identification and high-throughput analysis of the mechanism of action of active substances can be achieved by using specific changes in biomarkers. Jia Xiaoqiang from Tianjin University and others invented a method to improve the ability of Rhodococcus to degrade cycloaromatic pyrene by using metabolomics method (based on metabolomics to improve the degradation conditions of Rhodococcus to increase the degradation rate of polycyclic aromatic hydrocarbon pyrene. Publication number: CN107796906A ), using metabolomics methods combined with significant difference analysis to reveal the differences in the metabolites of Rhodococcus degrading PAH pyrene, and further explain the metabolic change mechanism related to the degradation of PAH pyrene. By analyzing the pyrene-degrading ability and metabolic level of Rhodococcus in different growth environments, metabolites related to pyrene degradation are found, thereby optimizing its degradation conditions and providing directions for improving the degradation rate of polycyclic aromatic hydrocarbon pyrene. This method can also be used It provides new ideas and methods for the optimization research of other microbial degradation conditions for the degradation of polycyclic aromatic hydrocarbons. Honkonen et al. of the American Procter & Gamble Company invented a method for analyzing the health status of human skin using metabolomic methods (Metabonomic methods to assess health of skin. Patent No. 7,761,242). Samples collected at different sites or at different times were used to diagnose skin conditions or evaluate the effects of various skin treatments, identifying biomarkers highly correlated with skin health. At present, there are no invention patents on the application of metabolomics in the production process of D-lactic acid.
对复杂的代谢组数据解析,除了传统的非监督方法和监督方法,近年来新兴起的一种名为加权关联网络分析(WGCNA)的方法在代谢组数据分析中也得到应用。随着质谱检测技术的发展,代谢组学分析产生大量的检测数据,采用传统的统计分析方法进行代谢组数据解析时面临着一个巨大的挑战,那就是如何将大量复杂的组数据转化成具有生物学意义的信息。首先,传统的统计分析方法很难识别那种变化倍数小的代谢物,造成分析结果的偏差;其次,传统分析方法更适用于对样品进行两两分析比较,无法同时对多种来源样品的高通量数据进行系统性的综合分析。而WGCNA是一种从高通量数据中挖掘模块(module)信息的算法,突破了上述两方面的约束。WGCNA一开始是用于转录组数据分析,在该方法中模块被定义为一组具有类似表达谱的基因,如果某些基因在一个生理过程或不同组织中总是具有相类似的表达变化,那么我们有理由认为这些基因在功能上是相关的,可以把他们定义为一个模块。这似乎有点类似于进行聚类分析所得到结果,但不同的是,WGCNA的聚类准则具有生物学意义,而非常规的聚类方法,因此该方法所得出的结果具有更高的可信度。目前,关于WGCNA在代谢组学数据分析中的应用,还未见有发明专利。For complex metabolome data analysis, in addition to traditional unsupervised methods and supervised methods, a newly emerging method called weighted correlation network analysis (WGCNA) has also been applied in metabolome data analysis. With the development of mass spectrometry detection technology, metabolomics analysis produces a large amount of detection data. When using traditional statistical analysis methods to analyze metabolomics data, we are faced with a huge challenge, that is, how to convert a large amount of complex group data into biological information of academic significance. First of all, it is difficult for traditional statistical analysis methods to identify metabolites with small multiples of change, resulting in deviations in the analysis results; second, traditional analysis methods are more suitable for pairwise analysis and comparison of samples, and cannot simultaneously analyze high levels of samples from multiple sources. Systematic comprehensive analysis of flux data. WGCNA is an algorithm for mining module information from high-throughput data, which breaks through the constraints of the above two aspects. WGCNA was originally used for transcriptome data analysis. In this method, a module is defined as a group of genes with similar expression profiles. If some genes always have similar expression changes in a physiological process or in different tissues, then We have reason to think that these genes are functionally related, and they can be defined as a module. This seems to be somewhat similar to the results obtained by cluster analysis, but the difference is that the clustering criteria of WGCNA have biological significance, rather than conventional clustering methods, so the results obtained by this method have higher credibility . At present, there are no invention patents regarding the application of WGCNA in metabolomics data analysis.
因此,本发明首次采用代谢组学结合加权关联网络分析模型(WGCNA)的方法,识别L.delbrueckii在多种发酵工艺条件下,发酵D-乳酸过程的显著代谢模块和Hubs代谢物,以指导后续的菌种提升和发酵工艺条件的进一步优化。Therefore, the present invention adopts the method of metabolomics combined with weighted correlation network analysis model (WGCNA) for the first time to identify the significant metabolic modules and Hubs metabolites of L. The improvement of strains and the further optimization of fermentation process conditions.
发明内容Contents of the invention
本发明的目的是提供一种将加权关联网络分析(WGCNA)应用于代谢组学数据解析,从而识别显著差异代谢模块和核心(Hubs)代谢物的方法;具体步骤如下:The purpose of the present invention is to provide a method of applying weighted correlation network analysis (WGCNA) to metabolomics data analysis, thereby identifying significant difference metabolic modules and core (Hubs) metabolites; the specific steps are as follows:
1)进行D-乳酸发酵工艺优化研究,包括通氮气维持厌氧发酵环境、调控发酵pH值、更换中和剂、替换廉价氮源,并将上述发酵条件进行组合优化,得到D-乳酸最优发酵工艺路线;1) Carry out research on the optimization of D-lactic acid fermentation process, including maintaining the anaerobic fermentation environment with nitrogen gas, adjusting the fermentation pH value, replacing neutralizers, replacing cheap nitrogen sources, and combining and optimizing the above fermentation conditions to obtain the optimal D-lactic acid Fermentation process route;
2)对步骤1)中各种发酵工艺条件下的胞内代谢物进行动态检测,获得D-乳酸发酵菌株胞内代谢动态变化特征曲线;2) Dynamically detect the intracellular metabolites under various fermentation process conditions in step 1), and obtain the dynamic change characteristic curve of the intracellular metabolism of the D-lactic acid fermentation strain;
3)采用WGCNA的数学模型对步骤2)中测定的胞内代谢物特征进行统计学解析,获得与各个发酵条件高度相关的显著代谢模块和Hubs代谢物。3) The mathematical model of WGCNA was used to statistically analyze the characteristics of intracellular metabolites determined in step 2), and significant metabolic modules and Hubs metabolites highly correlated with various fermentation conditions were obtained.
所述步骤1)中,在7.5L罐上进行L.delbrueckii(购买于中国普通微生物菌种保藏管理中心,菌种编号CGMCC1.2624)生产D-乳酸的发酵工艺条件优化,通入无菌氮气0.5h,排除发酵培养基中的初始溶解氧;将中和剂由碳酸钙分别更换成控制发酵pH的氢氧化钙和氢氧化钠,并优化发酵pH为5.9;将氮源由牛肉膏更换为蛋白胨和酵母粉的复合氮源。In the step 1), optimize the fermentation process conditions for the production of D-lactic acid by L.delbrueckii (purchased from China General Microorganism Culture Collection and Management Center, strain number CGMCC1.2624) on a 7.5L tank, and feed sterile nitrogen 0.5h, remove the initial dissolved oxygen in the fermentation medium; replace the neutralizer from calcium carbonate to calcium hydroxide and sodium hydroxide to control the fermentation pH, and optimize the fermentation pH to 5.9; replace the nitrogen source from beef extract to Complex nitrogen source of peptone and yeast powder.
所述步骤2)中采用GC-MS和LC-MS/MS技术对步骤1)中不同发酵工艺条件下的发酵液进行动态取样检测胞内代谢物,并进行处理和多元统计分析。In the step 2), GC-MS and LC-MS/MS techniques are used to dynamically sample the fermentation broth under different fermentation process conditions in the step 1) to detect intracellular metabolites, and perform processing and multivariate statistical analysis.
具体说明如下:The specific instructions are as follows:
1)进行D-乳酸发酵工艺优化研究,包括连续通入无菌氮气0.5h维持厌氧发酵环境、调控发酵pH值为5.9、将更换中和剂更换为氢氧化钙或氢氧化钠、将昂贵氮源牛肉膏替换廉价氮源蛋白胨和酵母粉复合氮源,并将上述发酵条件进行组合优化,得到D-乳酸最优发酵工艺路线。详细的发酵工艺条件说明见表1;1) Carry out research on the optimization of D-lactic acid fermentation process, including continuously feeding sterile nitrogen for 0.5h to maintain the anaerobic fermentation environment, adjusting the pH value of the fermentation to 5.9, replacing the neutralizer with calcium hydroxide or sodium hydroxide, and reducing expensive The nitrogen source beef extract replaces the cheap nitrogen source peptone and the compound nitrogen source of yeast powder, and the above fermentation conditions are combined and optimized to obtain the optimal fermentation process route of D-lactic acid. Detailed fermentation process conditions description is shown in Table 1;
2)采用气质联用(GC-MS)和液质联用(LC-MS/MS)技术平台,对1)中各种发酵工艺条件下的胞内代谢物进行动态检测,获得D-乳酸发酵菌株胞内代谢动态变化特征曲线;2) Using gas chromatography-mass spectrometry (GC-MS) and liquid chromatography-mass spectrometry (LC-MS/MS) technology platforms, dynamic detection of intracellular metabolites under various fermentation process conditions in 1) to obtain D-lactic acid fermentation The characteristic curve of the dynamic change of the intracellular metabolism of the strain;
3)采用加权关联网络分析(WGCNA)的数学模型对2)中测定的胞内代谢物特征进行统计学解析,获得与各个发酵条件高度相关的显著代谢模块和Hubs代谢物。3) The mathematical model of weighted correlation network analysis (WGCNA) was used to statistically analyze the characteristics of intracellular metabolites determined in 2), and significant metabolic modules and Hubs metabolites highly correlated with various fermentation conditions were obtained.
表1发酵工艺条件说明Table 1 Description of fermentation process conditions
本发明涉及加权关联网络分析(Weighted correlation network analysis,简称为WGCNA)进行代谢组学数据解析,从而识别显著差异代谢模块和核心(Hubs)代谢物的方法。本发明通过系统生物学手段,首次揭示德氏乳杆菌(Lactobacillus delbrueckii,实验室保藏,购买于中国普通微生物菌种保藏管理中心,菌种编号CGMCC1.2624)在不同发酵工艺条件下,高效发酵D-乳酸的胞内显著差异代谢模块和核心(Hubs)代谢物,以达到指导后续菌种提升和进一步发酵工艺条件优化之目的。The present invention relates to a weighted correlation network analysis (WGCNA for short) analysis of metabolomics data to identify significantly different metabolic modules and core (Hubs) metabolites. The present invention reveals for the first time that Lactobacillus delbrueckii (Lactobacillus delbrueckii, preserved in the laboratory, purchased from the China General Microorganism Culture Collection and Management Center, strain number CGMCC1.2624) can efficiently ferment D - Intracellular significantly different metabolic modules and core (Hubs) metabolites of lactic acid to achieve the purpose of guiding subsequent strain improvement and further optimization of fermentation process conditions.
附图说明Description of drawings
图1最优发酵工艺条件下,D-乳酸发酵的表观动力学特征曲线;Under the optimal fermentation process condition of Fig. 1, the apparent kinetic characteristic curve of D-lactic acid fermentation;
图2最优发酵工艺条件下的Hubs代谢物及其代谢关联分析图。Fig. 2 The analysis diagram of Hubs metabolites and their metabolic correlation under the optimal fermentation process conditions.
具体实施方式Detailed ways
为了使本发明的目的、技术方案和效果更加清晰,本发明结合附图和具体实施例进行说明:In order to make the purpose, technical scheme and effect of the present invention clearer, the present invention is described in conjunction with accompanying drawing and specific embodiment:
作为本发明的优选方式,提供一种在L.delbrueckii中利用代谢组学结合网络分析识别D-乳酸发酵过程中显著代谢模块和Hubs代谢物的方法。As a preferred mode of the present invention, a method for identifying significant metabolic modules and Hubs metabolites in the D-lactic acid fermentation process in L. delbrueckii is provided by using metabolomics combined with network analysis.
第一步,在7.5L罐上进行L.delbrueckii生产D-乳酸的发酵工艺条件优化,优化条件包括:通入无菌氮气0.5h,排除发酵培养基中的初始溶解氧,营造厌氧的发酵环境;将中和剂由碳酸钙分别更换成可以精确控制发酵pH的氢氧化钙和氢氧化钠,并优化发酵pH为5.9;将氮源由牛肉膏更换为蛋白胨和酵母粉的复合氮源,大大降低发酵原料成本;将以上发酵工艺条件进行组合优化,获得最佳D-乳酸发酵工艺路线。第二步,采用GC-MS和LC-MS/MS技术对第一步中不同发酵工艺条件下的发酵液进行动态取样检测胞内代谢物,并进行处理和多元统计分析(PCA);第三步,对第二步处理后的代谢组数据进行WGCNA分析,识别显著代谢模块和Hubs代谢物。The first step is to optimize the fermentation process conditions for the production of D-lactic acid by L.delbrueckii on a 7.5L tank. The optimized conditions include: feeding sterile nitrogen for 0.5h, excluding the initial dissolved oxygen in the fermentation medium, and creating anaerobic fermentation Environment; replace the neutralizer from calcium carbonate with calcium hydroxide and sodium hydroxide, which can precisely control the fermentation pH, and optimize the fermentation pH to 5.9; replace the nitrogen source from beef extract to a composite nitrogen source of peptone and yeast powder, The cost of fermentation raw materials is greatly reduced; the above fermentation process conditions are combined and optimized to obtain the best D-lactic acid fermentation process route. In the second step, GC-MS and LC-MS/MS technologies are used to dynamically sample and detect intracellular metabolites from the fermentation broth under different fermentation process conditions in the first step, and perform processing and multivariate statistical analysis (PCA); the third In the first step, WGCNA analysis is performed on the metabolome data processed in the second step to identify significant metabolic modules and Hubs metabolites.
实施例Example
1、L.delbrueckii生产D-乳酸的发酵工艺条件优化1. Optimization of the fermentation process conditions for the production of D-lactic acid by L.delbrueckii
德氏乳杆菌(Lactobacillus delbrueckii,实验室保藏,购买于中国普通微生物菌种Lactobacillus delbrueckii (Lactobacillus delbrueckii, laboratory preservation, purchased from China Common Microorganisms
保藏管理中心,菌种编号CGMCC1.2624)Collection Management Center, strain number CGMCC1.2624)
首先,将培养成熟的L.delbrueckii摇瓶种子按10%(v/v)的比例接种到装有4.5L发酵培养基的7.5L发酵罐中(吐温80 1g/L,蛋白胨22.5g/L,酵母浸粉7.5g/L,柠檬酸氢二铵2g/L,磷酸氢二钾2g/L,无水乙酸钠3g/L,无水硫酸镁0.2g/L,硫酸锰0.1g/L,葡萄糖80g/L,pH=5.9)。42℃,150rpm发酵48h。其余发酵条件如表1所示。发酵结果显示,在组合发酵工艺条件下,D-乳酸发酵产量高达133g/L(图1)。First, inoculate mature L.delbrueckii shake flask seeds into a 7.5L fermenter with 4.5L fermentation medium at a rate of 10% (v/v) (Tween 80 1g/L, peptone 22.5g/L , yeast extract powder 7.5g/L, diammonium hydrogen citrate 2g/L, dipotassium hydrogen phosphate 2g/L, anhydrous sodium acetate 3g/L, anhydrous magnesium sulfate 0.2g/L, manganese sulfate 0.1g/L, Glucose 80g/L, pH=5.9). 42°C, 150rpm fermentation for 48h. The remaining fermentation conditions are shown in Table 1. The fermentation results showed that under the combined fermentation process conditions, the D-lactic acid fermentation yield was as high as 133g/L (Figure 1).
2、胞内代谢物样品的制备2. Preparation of intracellular metabolite samples
(1)胞内代谢物提取(1) Extraction of intracellular metabolites
1)取20mL发酵液样品,快速加入等体积-40℃预冷的60%冷甲醇-水溶液,涡旋振荡2s,置于-20℃中,对细胞淬灭5min,终止胞内代谢反应,4℃下,5000rpm离心10min,弃上清,菌体沉淀用4℃,0.9%的NaCl溶液洗涤三次,洗涤后于4℃,5000rpm离心5min,弃上清,保留菌体,去除培养基组分。1) Take 20mL fermentation broth sample, quickly add an equal volume of -40°C pre-cooled 60% cold methanol-water solution, vortex for 2s, place in -20°C, quench the cells for 5min, and terminate the intracellular metabolic reaction, 4 Centrifuge at 5000 rpm for 10 min at 4 °C, discard the supernatant, wash the cell pellet three times with 0.9% NaCl solution at 4 °C, and centrifuge at 5000 rpm at 4 °C for 5 min after washing, discard the supernatant, retain the cells, and remove the medium components.
2)将洗涤后的菌体在-20℃预冷的研钵中用液氮研磨,破碎细胞壁,称取约200mg菌体于1.5mL EP管中,加入1mL提取液(50%(v/v),-40℃甲醇溶液),涡旋混匀后,用液氮反复冻融3次,每次1min。2) Grind the washed bacteria with liquid nitrogen in a mortar pre-cooled at -20°C to break the cell wall, weigh about 200 mg of the bacteria in a 1.5 mL EP tube, add 1 mL of extract (50% (v/v ), -40°C methanol solution), after vortex mixing, repeated freezing and thawing with liquid nitrogen 3 times, 1 min each time.
3)将上述粗提液在4℃条件下,8000rpm离心5min,取上清液至新的EP管中,下层菌体沉淀重新用0.5mL提取液(50%(v/v),-40℃甲醇溶液)提取,并于4℃条件下,8000rpm,离心5min后取上清,合并两次上清液后,再次于4℃条件下,8000rpm离心5min,取上清液。3) Centrifuge the above crude extract at 8000rpm for 5min at 4°C, take the supernatant into a new EP tube, and re-use 0.5mL extract (50% (v/v), -40°C methanol solution), and centrifuged at 8000rpm for 5min at 4°C to take the supernatant, combined the two supernatants, centrifuged at 8000rpm for 5min at 4°C again, and took the supernatant.
4)对同一样品,分别取100μL细胞提取液于两个干净EP管中,分别加入10μLsuccinic d4acid(0.1mg/mL)和10μL D-sorbitol-13C6(0.1mg/mL)作为GC-MS和LC-MS/MS的检测内标,充分混匀后,真空冷冻(-48℃)至样品完全干燥为止。4) For the same sample, take 100 μL of cell extract into two clean EP tubes, add 10 μL of succinic d4acid (0.1 mg/mL) and 10 μL of D-sorbitol-13C6 (0.1 mg/mL) respectively as GC-MS and LC- Internal standard for MS/MS detection, after mixing thoroughly, vacuum freeze (-48°C) until the sample is completely dry.
5)冷冻干燥后的样品于-80℃超低温冰箱中低温保藏备用或直接进行样品衍生化。5) Freeze-dried samples were stored in a -80°C ultra-low temperature freezer for later use or directly subjected to sample derivatization.
(2)样品的衍生化(2) Derivatization of samples
配制20mg/mL的甲氧基铵盐酸盐吡啶溶液,取50μL加入到完全干燥后的样品中,涡旋震荡混匀,并于金属浴中40℃条件下充分反应90min,再加入80μL三甲基硅烷基三氟乙酰胺,混匀,于金属浴中40℃条件下充分反应30min。将充分衍生化后的样品用0.22μm的油膜过滤,取150μL于进样瓶中,以备GC-MS和LC-MS/MS分析。Prepare 20 mg/mL methoxyammonium hydrochloride pyridine solution, take 50 μL and add it to the completely dried sample, vortex and oscillate to mix, and fully react in the metal bath at 40°C for 90 minutes, then add 80 μL trimethyl base silyl trifluoroacetamide, mix well, and fully react in a metal bath at 40°C for 30 minutes. The fully derivatized sample was filtered through a 0.22 μm oil membrane, and 150 μL was taken into a sample vial for GC-MS and LC-MS/MS analysis.
3、胞内代谢物检测3. Detection of intracellular metabolites
(1)GC-MS检测(1) GC-MS detection
GC-MS系统:气相色谱(Agilent 6890N)、质谱(Agilent 9575C MSD)和自动进样器(Agilent 5183-2085)。色谱柱采用DB-5MS毛细管柱(30mm×0.25mm,0.25μm,AgilentTechnologies)。色谱条件如下:进样量1μL,分流比1:1,进样口温度和界面温度为280℃,载气(氦气,恒压),流速为1.0mL/min。柱温升温程序:70℃保持2min;5℃/min升温至290℃,保持3min。质谱参数:采用电子轰击离子源,电子轰击能量为70eV,离子源温度为250℃,电流为40μA,扫描范围50-650m/z。GC-MS system: gas chromatography (Agilent 6890N), mass spectrometry (Agilent 9575C MSD) and autosampler (Agilent 5183-2085). The chromatographic column adopts DB-5MS capillary column (30mm×0.25mm, 0.25μm, Agilent Technologies). The chromatographic conditions were as follows: injection volume 1 μL, split ratio 1:1, inlet temperature and interface temperature 280 °C, carrier gas (helium, constant pressure), flow rate 1.0 mL/min. Column temperature rise program: keep at 70°C for 2 minutes; raise the temperature to 290°C at 5°C/min and keep for 3 minutes. Mass spectrometry parameters: Electron bombardment ion source is used, the electron bombardment energy is 70eV, the ion source temperature is 250°C, the current is 40μA, and the scanning range is 50-650m/z.
(2)胞内代谢物LC-MS/MS检测(2) LC-MS/MS detection of intracellular metabolites
在GC-MS检测中,因磷酸戊糖途径(PP途径)和糖酵解途径(EMP途径)中的部分胞内磷酸糖类代谢物无法检出,如6-磷酸葡萄糖(G6P),6-磷酸果糖(F6P),1,6-二磷酸果糖(F-1,6-P),3-磷酸甘油醛(3PG),磷酸烯醇式丙酮酸(PEP),5-磷酸核酮糖(RiBP),5-磷酸核糖(R5P),5-磷酸木酮糖(X5P),7-磷酸景天庚酮糖(S7P)和4-磷酸赤藓糖(E4P)。因此,针对上述代谢物的检测本研究中采用LC-MS/MS系统方法进行检测,分别采用液相色谱(Perkin-Elmer series 200pump)和Symmetry C18柱(3.9mm×150mm,5μm,Waters ChromatographyBV,Etten Leu,The Netherlands)分离和配备有电子离子喷雾源(Turbo Ion Spray)的API-3000串联质谱(PE-Sciex)进行质谱鉴定,其中离子源参数为:离子喷雾电压-2500V,离子源温度400℃,喷雾气流和碰撞气流分别设定为10和4。In GC-MS detection, some intracellular phosphate sugar metabolites in the pentose phosphate pathway (PP pathway) and glycolysis pathway (EMP pathway) cannot be detected, such as glucose 6-phosphate (G6P), 6- Fructose phosphate (F6P), fructose 1,6-diphosphate (F-1,6-P), glyceraldehyde 3-phosphate (3PG), phosphoenolpyruvate (PEP), ribulose 5-phosphate (RiBP ), ribose 5-phosphate (R5P), xylulose 5-phosphate (X5P), sedoheptulose 7-phosphate (S7P) and erythrose 4-phosphate (E4P). Therefore, for the detection of the above metabolites, the LC-MS/MS system method was used for detection in this study. Leu, The Netherlands) and API-3000 tandem mass spectrometer (PE-Sciex) equipped with an electronic ion spray source (Turbo Ion Spray) for mass spectrometry identification, where the ion source parameters are: ion spray voltage -2500V, ion source temperature 400 ° C , the spray airflow and collision airflow were set to 10 and 4, respectively.
4、代谢物数据处理及多元统计分析4. Metabolite data processing and multivariate statistical analysis
(1)GC-MS检测的质谱图采用AMDIS(Version3.2,National Institute ofStandards and Technology,Gaithers burg,MD,USA),NIST(National Institute ofStandards and Technology mass spectral library,2005)和GMD(Golm MetabolomeDatabase)等Agilent配套软件首先进行去卷积、降噪、峰面积积分和代谢物鉴定,再对每个鉴定代谢物进行去衍生化基团处理,即得到每个代谢物数据。采用GC-MS共鉴定和半定量得到80个胞内代谢物。(1) The mass spectrogram detected by GC-MS adopts AMDIS (Version3.2, National Institute of Standards and Technology, Gaithersburg, MD, USA), NIST (National Institute of Standards and Technology mass spectral library, 2005) and GMD (Golm Metabolome Database) Agilent software such as Agilent first performs deconvolution, noise reduction, peak area integration and metabolite identification, and then performs derivatization group processing on each identified metabolite to obtain the data of each metabolite. 80 intracellular metabolites were co-identified and semi-quantified by GC-MS.
(2)LC-MS/MS检测数据则采用相应的代谢物标准品测定数据进行定量/定性分析,并通过Window NT software(Ver.1.3.1)对每个代谢物和内标物进行分析,最终获得每个代谢物的浓度。采用LC-MS/MS共鉴定和半定量得到10个胞内代谢物。(2) LC-MS/MS detection data is quantitatively/qualitatively analyzed using the corresponding metabolite standard measurement data, and each metabolite and internal standard are analyzed by Window NT software (Ver.1.3.1), Finally the concentration of each metabolite was obtained. 10 intracellular metabolites were identified and semi-quantified by LC-MS/MS.
(3)GC-MS检测出的所有代谢物通过代谢物峰面积除以样品干重和相应内标物峰面积进行标准化,LC-MS/MS所检测的代谢物的绝对浓度采用GC-MS中相同的方法进行标准化,将两组数据合并后进行归一化和尺度化,采用SIMCA-P package(Ver 11.5;Umetrics,Umea,Sweden)进行主成分分析。每个样品实施5次独立生物学重复,数据采用平均值加标准差表示。主成分分析结果显示,不同发酵工艺条件下,胞内代谢显现出巨大的差异。(3) All metabolites detected by GC-MS were normalized by dividing the metabolite peak area by the dry weight of the sample and the peak area of the corresponding internal standard, and the absolute concentration of the metabolites detected by LC-MS/MS The same method was used for standardization. The two sets of data were combined for normalization and scaling, and the SIMCA-P package (Ver 11.5; Umetrics, Umea, Sweden) was used for principal component analysis. Five independent biological repetitions were performed for each sample, and the data were expressed as the mean plus standard deviation. The results of principal component analysis showed that there were huge differences in intracellular metabolism under different fermentation conditions.
5、WGCNA方法的构建5. Construction of WGCNA method
依据WGCNA标准运算程序,对GC-MS和LC-MS/MS检测并进行归一化处理后的代谢组数据构建了相关性网络分析模型。具体流程如下:首先计算出代谢组数据的加权皮尔森相关系数矩阵,然后将其转换成代谢物连接强度矩阵,同时采用拓扑重叠(topologicaloverlap,TO)计算代谢物间的关联程度,获得代谢物相似性关联网络,并以TO为基础进行代谢物相异度层次聚类,建立分层聚类树,采用动态剪切树算法将具有高度关联性代谢物聚到一起,最终找到9个具有生物学意义的显著差异代谢模块如表2所示。Hub metabolites(Hubs)的鉴定则是在WGCNA分析确定的显著性模块基础上,将显著性代谢模块数据进一步输入到VisANT和Cytoscape软件进行可视化处理,通过对代谢物的连接度进行排序后筛选出8个具有高连接度的代谢物,即为Hub metabolites(图2)。According to WGCNA standard operating procedures, a correlation network analysis model was constructed for the metabolome data detected by GC-MS and LC-MS/MS and normalized. The specific process is as follows: first calculate the weighted Pearson correlation coefficient matrix of the metabolome data, and then convert it into a metabolite connection strength matrix, and use topological overlap (TO) to calculate the degree of correlation between metabolites to obtain metabolite similarity Based on TO, hierarchical clustering of metabolite dissimilarity was carried out, a hierarchical clustering tree was established, and highly correlated metabolites were gathered together by dynamic cutting tree algorithm, and finally 9 metabolites with biological Significant differences in the significance of the metabolic modules are shown in Table 2. The identification of Hub metabolites (Hubs) is based on the significant modules determined by the WGCNA analysis, and the data of the significant metabolic modules are further input into VisANT and Cytoscape software for visualization, and 8 are screened out by sorting the connectivity of metabolites. A metabolite with high connectivity is Hub metabolites (Figure 2).
表2:显著差异模Table 2: Significant difference mode
6、种子培养条件6. Seed culture conditions
取2mL甘油管保藏的菌株,接种于200mL种子培养基中((吐温80 1g/L,蛋白胨10g/L,酵母浸粉5g/L,柠檬酸氢二铵2g/L,磷酸氢二钾2g/L,无水乙酸钠3g/L,无水硫酸镁0.2g/L,硫酸锰0.1g/L,葡萄糖20g/L,pH=5.9),42℃静置培养至对数生长期,一般为11~13h,菌体刚开始沉淀。菌体和上清液之间的分层并不明显,镜检时大多数菌体为短杆状,也有部分处于分裂状态的长杆状。此时菌体OD600=1.5~2.1之间。Get the bacterial strain preserved in 2mL glycerol tube, inoculate in 200mL seed medium ((Tween 80 1g/L, peptone 10g/L, yeast extract powder 5g/L, diammonium hydrogen citrate 2g/L, dipotassium hydrogen phosphate 2g /L, anhydrous sodium acetate 3g/L, anhydrous magnesium sulfate 0.2g/L, manganese sulfate 0.1g/L, glucose 20g/L, pH=5.9), 42 ℃ static culture to logarithmic growth phase, generally At 11-13 hours, the bacterial cells just began to precipitate. The stratification between the bacterial cells and the supernatant was not obvious, and most of the bacterial cells were short rod-shaped during microscopic examination, and some were long rod-shaped in a split state. At this time, the bacterial cells Body OD600 = between 1.5 and 2.1.
7、D-乳酸产量和手性纯度的测定7. Determination of D-lactic acid yield and chiral purity
(1)D-乳酸产量采用高效液相色谱(Agilent 1200,USA)进行检测。具体操作如下:(1) The production of D-lactic acid was detected by high performance liquid chromatography (Agilent 1200, USA). The specific operation is as follows:
1)取1mL发酵液,10000rpm离心2min。1) Take 1mL fermentation broth and centrifuge at 10000rpm for 2min.
2)取上清液100μL,加入到900μL 0.1M稀硫酸溶液中,混匀后10000rpm离心5min。2) Take 100 μL of the supernatant, add it to 900 μL of 0.1M dilute sulfuric acid solution, mix well and centrifuge at 10,000 rpm for 5 min.
3)取上清液过0.22μm的水系滤膜,用于高效液相色谱分析:A:色谱柱HPX-87H(250mm×4.6mm,BioRad,America),流动相:2.5mM硫酸溶液,流速0.4ml/min,柱温65℃,利用视差监测仪检测,进样量20μL;B:色谱柱ZOBAX SB-C18(250mm×4.6mm,Agilent,America),流动相:5mM硫酸溶液,流速0.5mL/min,柱温30℃,紫外检测波长210nm,进样量20μL。3) Take the supernatant and pass it through a 0.22 μm water filter membrane for HPLC analysis: A: Chromatographic column HPX-87H (250mm×4.6mm, BioRad, America), mobile phase: 2.5mM sulfuric acid solution, flow rate 0.4 ml/min, column temperature 65°C, detection by parallax monitor, injection volume 20 μL; B: chromatographic column ZOBAX SB-C18 (250mm×4.6mm, Agilent, America), mobile phase: 5mM sulfuric acid solution, flow rate 0.5mL/ min, column temperature 30°C, UV detection wavelength 210nm, injection volume 20μL.
(2)D-乳酸手性纯度采用高效液相色谱进行分离测定。具体操作如下:(2) The chiral purity of D-lactic acid was separated and determined by high performance liquid chromatography. The specific operation is as follows:
1)取1mL发酵液,10000rpm离心2min。1) Take 1mL fermentation broth and centrifuge at 10000rpm for 2min.
2)取上清液100μL,加入到900μL水中,混匀后10000rpm离心5min。2) Take 100 μL of the supernatant, add it into 900 μL of water, mix well and centrifuge at 10,000 rpm for 5 min.
3)取上清液过0.22μm的水系滤膜,用于高效液相色谱分析:色谱柱Chiralseparation columns CRS10W(50mm×4.6mm,MCI GEL,Japan),流动相:2mM硫酸铜溶液,流速0.5ml/min,柱温25℃,紫外检测波长254nm,进样量20μL。3) Take the supernatant and pass it through a 0.22 μm water-based filter membrane for HPLC analysis: Chromatographic column Chiralseparation columns CRS10W (50mm×4.6mm, MCI GEL, Japan), mobile phase: 2mM copper sulfate solution, flow rate 0.5ml /min, the column temperature is 25°C, the UV detection wavelength is 254nm, and the injection volume is 20μL.
本发明公开和提出的利用加权关联网络分析识别D-乳酸发酵过程显著代谢模块和Hubs代谢物的方法,本领域技术人员可通过借鉴本文内容,适当改变条件路线等环节实现,尽管本发明的方法和技术已通过较佳实施例子进行了描述,相关技术人员明显能在不脱离本发明内容、精神和范围内对本文所述的方法和技术路线进行改动或重新组合,来实现最终的制备技术。特别需要指出的是,所有相类似的替换和改动对本领域技术人员来说是显而易见的,他们都被视为包括在本发明精神、范围和内容中。The method disclosed and proposed by the present invention using weighted association network analysis to identify significant metabolic modules and Hubs metabolites in the D-lactic acid fermentation process can be realized by those skilled in the art by referring to the content of this article and appropriately changing the conditional route. Although the method of the present invention The technologies and technologies have been described through preferred implementation examples, and those skilled in the art can obviously modify or recombine the methods and technical routes described herein without departing from the content, spirit and scope of the present invention to realize the final preparation technology. In particular, it should be pointed out that all similar substitutions and modifications will be obvious to those skilled in the art, and they are all considered to be included in the spirit, scope and content of the present invention.
Claims (3)
- The method that 1.WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins;It is characterized in that steps are as follows:1) D-ALPHA-Hydroxypropionic acid fermentation technology optimization research is carried out, including logical nitrogen maintains anaerobic fermentation environment, regulation and control fermentation pH value, replaces Neutralizer replaces cheap nitrogen source, and above-mentioned fermentation condition is combined optimization, obtains the optimal zymotechnique route of D-ALPHA-Hydroxypropionic acid;2) dynamic detection is carried out to the intracellular metabolin under various technological condition for fermentation in step 1), obtains D-ALPHA-Hydroxypropionic acid fermentation strain Intracellular is metabolized dynamic change characterization curve;3) mathematical model of WGCNA is used to carry out statistics parsing to the intracellular metabolites characteristic measured in step 2), obtain with The highly relevant notable metabolism module of each fermentation condition and Hubs metabolins.
- 2. the method as described in claim 1 carries out L.delbrueckii productions it is characterized in that in step 1) on 7.5L tanks The optimization of fermentation condition of D-ALPHA-Hydroxypropionic acid is passed through sterile nitrogen 0.5h, excludes the initial dissolution oxygen in fermentation medium;It will neutralize Agent is replaced with the calcium hydroxide and sodium hydroxide of control fermentation pH by calcium carbonate respectively, and it is 5.9 to optimize fermentation pH;By nitrogen source by Beef extract is changed to the compound nitrogen source of peptone and yeast powder.
- 3. the method as described in claim 1, it is characterized in that using GC-MS and LC-MS/MS technologies in step 1) in step 2) Zymotic fluid under different fermentations process conditions carries out Dynamic sampling and detects intracellular metabolin, and carries out processing and multivariate statistics point Analysis.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810524408.7A CN108753855A (en) | 2018-05-28 | 2018-05-28 | The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810524408.7A CN108753855A (en) | 2018-05-28 | 2018-05-28 | The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108753855A true CN108753855A (en) | 2018-11-06 |
Family
ID=64002761
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810524408.7A Pending CN108753855A (en) | 2018-05-28 | 2018-05-28 | The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108753855A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115376628A (en) * | 2021-11-29 | 2022-11-22 | 广州市唯誉智合科技有限公司 | A method for constructing large-scale metabolome database based on weighted network |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1952164A (en) * | 2006-11-10 | 2007-04-25 | 南京工业大学 | Combined fermentation process for producing D-lactic acid |
| CN102286551A (en) * | 2011-07-01 | 2011-12-21 | 南京工业大学 | Fermentation process regulation and control method of fumaric acid radical-producing mould |
| CN103088104A (en) * | 2013-01-12 | 2013-05-08 | 天津大学 | Method for optimizing fermentation medium by improving rapamycin production by using metabolic profiling analysis |
| CN104419647A (en) * | 2013-09-06 | 2015-03-18 | 中国医学科学院药用植物研究所 | Muscodor malipoensis with biocontrol effect |
| CN104450834A (en) * | 2014-12-04 | 2015-03-25 | 天津大学 | Method of increasing yield of spinosad by improving fermentation condition of saccharopolyspora spinosa based on metabonomics |
| CN104704364A (en) * | 2012-06-15 | 2015-06-10 | 韦恩州立大学 | Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome |
| CN106591136A (en) * | 2016-12-28 | 2017-04-26 | 昆明藻能生物科技有限公司 | High-glucose-tolerance crypthecodinium cohnii obtained from orient domestication, and preparation method and application thereof |
| WO2018049268A1 (en) * | 2016-09-08 | 2018-03-15 | Duke University | Biomarkers for the diagnosis and characterization of alzheimer's disease |
-
2018
- 2018-05-28 CN CN201810524408.7A patent/CN108753855A/en active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1952164A (en) * | 2006-11-10 | 2007-04-25 | 南京工业大学 | Combined fermentation process for producing D-lactic acid |
| CN102286551A (en) * | 2011-07-01 | 2011-12-21 | 南京工业大学 | Fermentation process regulation and control method of fumaric acid radical-producing mould |
| CN104704364A (en) * | 2012-06-15 | 2015-06-10 | 韦恩州立大学 | Biomarker test for prediction or early detection of preeclampsia and/or hellp syndrome |
| CN103088104A (en) * | 2013-01-12 | 2013-05-08 | 天津大学 | Method for optimizing fermentation medium by improving rapamycin production by using metabolic profiling analysis |
| CN104419647A (en) * | 2013-09-06 | 2015-03-18 | 中国医学科学院药用植物研究所 | Muscodor malipoensis with biocontrol effect |
| CN104450834A (en) * | 2014-12-04 | 2015-03-25 | 天津大学 | Method of increasing yield of spinosad by improving fermentation condition of saccharopolyspora spinosa based on metabonomics |
| WO2018049268A1 (en) * | 2016-09-08 | 2018-03-15 | Duke University | Biomarkers for the diagnosis and characterization of alzheimer's disease |
| CN106591136A (en) * | 2016-12-28 | 2017-04-26 | 昆明藻能生物科技有限公司 | High-glucose-tolerance crypthecodinium cohnii obtained from orient domestication, and preparation method and application thereof |
Non-Patent Citations (2)
| Title |
|---|
| BIN ZHANG等: "A general framework for weighted gene co-expression network analysis", 《STAT APPL GENET MOL BIOL》 * |
| JIANGXIN WANG等: "Global Metabolomic and Network analysis of Escherichia coli Responses to Exogenous Biofuels", 《JOURNAL OF PROTEOME RESEARCH》 * |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN115376628A (en) * | 2021-11-29 | 2022-11-22 | 广州市唯誉智合科技有限公司 | A method for constructing large-scale metabolome database based on weighted network |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Zhang et al. | Proteomic and metabolic elucidation of solar-powered biomanufacturing by bio-abiotic hybrid system | |
| Duportet et al. | The biological interpretation of metabolomic data can be misled by the extraction method used | |
| Wen et al. | Applications of multi-omics techniques to unravel the fermentation process and the flavor formation mechanism in fermented foods | |
| Xu et al. | Recent developments and applications of metabolomics in microbiological investigations | |
| Sun et al. | The abundant marine bacterium Pelagibacter simultaneously catabolizes dimethylsulfoniopropionate to the gases dimethyl sulfide and methanethiol | |
| Bennette et al. | An LC–MS-based chemical and analytical method for targeted metabolite quantification in the model cyanobacterium Synechococcus sp. PCC 7002 | |
| Wang et al. | Metabolomic analysis reveals key metabolites related to the rapid adaptation of Saccharomyce cerevisiae to multiple inhibitors of furfural, acetic acid, and phenol | |
| Luo et al. | The characteristics of patulin degradation by probiotic yeast-Pichia guilliermondii S15-8 | |
| Czajka et al. | Application of stable isotope tracing to elucidate metabolic dynamics during Yarrowia lipolytica α-ionone fermentation | |
| Li et al. | The changes of chemical molecular components in soil organic matter are associated with fungus Mortierella capitata K. | |
| Hu et al. | Metabolites contributing to Rhizoctonia solani AG-1-IA maturation and sclerotial differentiation revealed by UPLC-QTOF-MS metabolomics | |
| Kim et al. | Elucidation of ethanol tolerance mechanisms in Saccharomyces cerevisiae by global metabolite profiling | |
| Wang et al. | A metabolomics-based method for studying the effect of yfcC gene in Escherichia coli on metabolism | |
| Wang et al. | Insight into the surfactin production of Bacillus velezensis B006 through metabolomics analysis | |
| Guan et al. | Comparative metabolomics analysis of the key metabolic nodes in propionic acid synthesis in Propionibacterium acidipropionici | |
| Tugizimana et al. | Time-resolved decoding of metabolic signatures of in vitro growth of the hemibiotrophic pathogen Colletotrichum sublineolum | |
| Wang et al. | Comparative metabolic profiling reveals the key role of amino acids metabolism in the rapamycin overproduction by Streptomyces hygroscopicus | |
| Shen et al. | Quantitative metabolic network profiling of Escherichia coli: An overview of analytical methods for measurement of intracellular metabolites | |
| Ye et al. | Metabolomic profiling reveals biomarkers for diverse flesh colors in jelly fungi (Auricularia cornea) | |
| Li et al. | Straw input can parallelly influence the bacterial and chemical characteristics of maize rhizosphere | |
| Li et al. | Innovative omics strategies in fermented fruits and vegetables: Unveiling nutritional profiles, microbial diversity, and future prospects | |
| Huang et al. | Integrative metabolomics and proteomics allow the global intracellular characterization of Bacillus subtilis cells and spores | |
| Bhoite et al. | Statistical optimization of bioprocess parameters for enhanced gallic acid production from coffee pulp tannins by Penicillium verrucosum | |
| CN108627585A (en) | The method that significant difference expresses albumen in D-ALPHA-Hydroxypropionic acid fermentation process is identified based on iTRAQ protein sciences | |
| CN108753855A (en) | The method that WGCNA identifies D-ALPHA-Hydroxypropionic acid fermentation process notable module and Hubs metabolins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181106 |
|
| RJ01 | Rejection of invention patent application after publication |